UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 174 filers reported holding UNIQURE NV in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $243,311 | -42.4% | 36,261 | -1.7% | 0.00% | 0.0% |
Q2 2023 | $422,702 | -46.0% | 36,885 | -5.1% | 0.00% | -50.0% |
Q1 2023 | $782,560 | -13.8% | 38,856 | -3.0% | 0.00% | -33.3% |
Q4 2022 | $907,775 | +13.6% | 40,043 | -6.0% | 0.00% | 0.0% |
Q3 2022 | $799,000 | +10.7% | 42,581 | +9.9% | 0.00% | +50.0% |
Q2 2022 | $722,000 | +39.1% | 38,733 | +35.0% | 0.00% | +100.0% |
Q1 2022 | $519,000 | – | 28,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |